Drug Markets/Levobunolol Hydrochloride

Levobunolol Hydrochloride

3 NDCs across 1 manufacturer|3 Generic,0 Brand

Levobunolol Hydrochloride is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Dec 19, 1985, and the first generic was approved Mar 4, 1994.

Levobunolol Hydrochloride is available as 3 NDCs from 1 manufacturer (3 generic, 0 brand), with NADAC prices from $0.79 to $2.82 per MLthe most expensive product costs about 3.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

3G / 0B

Manufacturers

1

competing in market

Price Spread

$0.79 – $2.82

per ML

7d Activity

12 flat

avg +1.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing LEVOBUNOLOL HYDROCHLORIDE

Drug Portfolio

3 NDCs total, 3 shown

Frequently Asked Questions

What is Levobunolol Hydrochloride used to treat?

Levobunolol Hydrochloride is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.

When did Levobunolol Hydrochloride become available as a generic?

FDA approved the first generic Levobunolol Hydrochloride (ANDA) on Mar 4, 1994.

How many Levobunolol Hydrochloride products are on the market?

The Levobunolol Hydrochloride drug market contains 3 NDCs from 1 manufacturer — 3 generic and 0 brand products.

What is the price range for Levobunolol Hydrochloride?

NADAC reference prices for Levobunolol Hydrochloride range from $0.7930 to $2.8165 per ML — the most expensive product costs about 3.6× the cheapest.

Which manufacturers make Levobunolol Hydrochloride?

1 manufacturer lists Levobunolol Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Bausch & Lomb Incorporated (3).

How has the price of Levobunolol Hydrochloride changed recently?

Over the past 7 days, 1 Levobunolol Hydrochloride NDC rose and 0 fell, with a market-wide average change of +1.0%.